Inventor · disambiguated record
Thuy-Anh Tran
Also filed as: TRAN THUY-ANH
29 granted patents·20 pending applications·200 citations·filing 2002–2024
97Inventor score
Files withARENA PHARM INC36TRAN THUY-ANH6TEEGARDEN BRADLEY4SEKIGUCHI YOSHINORI1TAISHO PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
49 records- 0195US10479797B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2019·Granted Nov 19, 2019·9 cites·30 claims
- 0293US8148417B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2007·Granted Apr 3, 2012·21 cites·12 claims
- 0392US10668033B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Jun 2, 2020·4 cites·32 claims
- 0492US8148418B2Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2007·Granted Apr 3, 2012·16 cites·12 claims
- 0591US10927123B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2020·Granted Feb 23, 2021·2 cites·6 claims
- 0691US10662200B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2019·Granted May 26, 2020·3 cites·24 claims
- 0791US9328107B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2014·Granted May 3, 2016·12 cites·34 claims
- 0891USRE45336EPrimary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2007·Granted Jan 13, 2015·12 cites·22 claims
- 0991US8895776B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2009·Granted Nov 25, 2014·23 cites·98 claims
- 1091US8664258B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2012·Granted Mar 4, 2014·14 cites·25 claims
- 1190US9221755B2Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2014·Granted Dec 29, 2015·11 cites·30 claims
- 1290USRE45337EEthers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2007·Granted Jan 13, 2015·11 cites·22 claims
- 1389US9012478B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2013·Granted Apr 21, 2015·4 cites·47 claims
- 1489US8680119B2Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2012·Granted Mar 25, 2014·11 cites·24 claims
- 1588US9663500B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted May 30, 2017·3 cites·13 claims
- 1686US11560386B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2020·Granted Jan 24, 2023·1 cites·19 claims
- 1786US11339172B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related theretoARENA PHARM INC·Filed 2018·Granted May 24, 2022·3 cites·26 claims
- 1886US2025009693A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2024·Application pending·0 cites
- 1985US11098034B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Granted Aug 24, 2021·1 cites·4 claims
- 2083US8940891B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2009·Granted Jan 27, 2015·6 cites·44 claims
- 2182US10689372B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Jun 23, 2020·1 cites·21 claims
- 2282US10214518B2Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Feb 26, 2019·2 cites·15 claims
- 2382US7544690B2MCH receptor antagonistsTAISHO PHARMACEUTICAL CO LTD·Filed 2002·Granted Jun 9, 2009·27 cites·4 claims
- 2482US2023404954A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2023·Application pending·0 cites
- 2581USRE50267EModulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2022·Granted Jan 14, 2025·0 cites·35 claims
- 2679US2023121825A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2022·Application pending·0 cites
- 2777US10793529B2Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2018·Granted Oct 6, 2020·1 cites·19 claims
- 2877US9987252B2Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2016·Granted Jun 5, 2018·1 cites·15 claims
- 2974US10138210B2Substituted pyridazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2016·Granted Nov 27, 2018·1 cites·33 claims
- 3071US2011224262A1Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2009·Application pending·0 cites
- 3170US11987588B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related theretoARENA PHARM INC·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 3269US2020385357A1Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsARENA PHARM INC·Filed 2020·Application pending·0 cites
- 3369US2020247755A1Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2019·Application pending·0 cites
- 3469US2020375930A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 3566US2019284200A1Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2017·Application pending·0 cites
- 3665US2019070149A1Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Application pending·0 cites
- 3763US2015126527A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2014·Application pending·0 cites
- 3861US10450276B2Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
- 3961US2015191454A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2014·Application pending·0 cites
- 4059US2013217706A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2012·Application pending·0 cites
- 4157US2024376090A1Isoxazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disordered related theretoARENA PHARM INC·Filed 2021·Application pending·0 cites
- 4256US2015265576A1Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Application pending·0 cites
- 4356US2015174102A1Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Application pending·0 cites
- 4446US9365511B2Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disordersARENA PHARM INC·Filed 2014·Granted Jun 14, 2016·0 cites·28 claims
- 4543US2008200491A11,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor NovelTRAN THUY-ANH·Filed 2006·Application pending·0 cites
- 4641US2005197350A1Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereofARENA PHARM INC·Filed 2004·Application pending·0 cites
- 4740US2014309192A1Modulators of the g protein-coupled mas receptor and the treatment of disorders related theretoARENA PHARM INC·Filed 2012·Application pending·0 cites
- 4837US2007010671A1Novel quinazoline derivatives and methods of treatment related to the use thereofSEKIGUCHI YOSHINORI·Filed 2004·Application pending·0 cites
- 4936US2009036448A1Pyrimidine derivatives and methods of treatment related to the use thereofTAISHO PHARMECUTICAL CO LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thuy-Anh Tran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →